TFS Trial Form Support AB

BMS and venture capital giant form new company

The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a new biotech company. The company wil...

GU Ventures AB

US Health Secretary Kennedy dismisses all vaccine experts – assembles new committee

Robert F. Kennedy Jr. has dismissed all 17 members of the CDC’s vaccine advisory panel. A new group of experts will be appointed directly by the Health Secretar...

Novo Nordisk appoints Mike Doustdar as new CEO

The Danish pharmaceutical giant Novo Nordisk has appointed Mike Doustdar as its new CEO. At the same time, the company announced it was lowering its forecasts –...

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

The art of successful licensing – “A lot has to align”

Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies...

Getinge and Neobiomics received Swecare's export awards

Two companies received awards during Swecare's annual conference.

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...

Pharma Outsourcing – Find the right partner

Swetrial tar form – så ska partnerskapet stärka kliniska prövningar

Ett nationellt partnerskap med namnet Swetrial ska skapa bättre förutsättningar för kliniska prövningar. Läkemedelsverket presenterar nu en delredovisning och e...

Klartecken i EU för ny behandling av blodcancer

EU-kommissionen har godkänt GSK:s läkemedel Blenrep för behandling av vuxna med återkommande eller behandlingsresistenta former av multipelt myelom.

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Aqilion's licensing journey: From Merck partnership to new opportunities

Be extremely meticulous with your scientific data, but spend just as much time and effort on business development. That piece of advice comes from Aqilion's CEO...

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

Medeon AB

Sahlgrenska Science Park

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Zelmic

ProPharma

Join the premier metrology and quality assurance event of the year

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Double Bond avslutar licensavtal efter uteblivna betalningar

Läkemedelsbolaget Double Bond Pharmaceuticals avslutar ett förvärvsavtal med amerikanska Vivo Biopharma, som man anklagar för att inte ha uppfyllt sina åtaganden i form av milstolpsbetalningar....

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.